BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10213280)

  • 1. Hemodynamic effects of celiprolol in patients with ischemic and non-ischemic cardiomyopathy.
    Hennersdorf MG; Perings C; Vester EG
    Int J Cardiol; 1999 Mar; 68(3):289-95. PubMed ID: 10213280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure.
    Nakamura Y; Ryoke T; Tanaka N; Ohkusa T; Matsuzaki M
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):171-8. PubMed ID: 9475257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol.
    Sanderson JE; Chan SK; Yu CM; Yeung LY; Chan WM; Raymond K; Chan KW; Woo KS
    Heart; 1998 Jan; 79(1):86-92. PubMed ID: 9505927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hemodynamic effects of beta-blockers in patients with severe congestive heart failure: comparison of celiprolol and esmolol.
    Felix SB; Stangl V; Kieback A; Doerffel W; Staudt A; Wernecke KD; Baumann G; Stangl K
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):666-71. PubMed ID: 11602813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive inotropic effects due to partial agonistic activity of the beta-adrenoceptor antagonist celiprolol following amplification of cAMP formation in failing human myocardium.
    Böhm M; Schulz C; Schwinger RH; Erdmann E
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):479-89. PubMed ID: 1279296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of single oral doses of nebivolol and celiprolol on airways in patients with mild asthma.
    Cazzola M; Noschese P; D'Amato M; D'Amato G
    Chest; 2000 Nov; 118(5):1322-6. PubMed ID: 11083681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can intravenous beta-blockade predict long-term hemodynamic benefit in chronic congestive heart failure secondary to ischemic heart disease? A comparison of intravenous with oral carvedilol.
    DasGupta P; Lahiri A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S62-7. PubMed ID: 1378153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of carvedilol in congestive heart failure secondary to coronary artery disease.
    Das Gupta P; Broadhurst P; Raftery EB; Lahiri A
    Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties. The CELICARD Group.
    Witchitz S; Cohen-Solal A; Dartois N; Weisslinger N; Juste K; Darmon JY
    Am J Cardiol; 2000 Jun; 85(12):1467-71. PubMed ID: 10856394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker.
    Sanderson JE; Chan WW; Hung YT; Chan SK; Shum IO; Raymond K; Woo KS
    Br Heart J; 1995 Nov; 74(5):502-7. PubMed ID: 8562234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rest and exercise haemodynamic evaluation of a new cardio-selective beta-adrenoceptor blocker celiprolol alone and in combination with nitroglycerine in ischaemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    Br J Clin Pharmacol; 1986 Dec; 22(6):697-706. PubMed ID: 2882772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.
    Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S138-44. PubMed ID: 2427845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
    Silke B; Guy S; Riddell JG
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic blockade in dilated cardiomyopathy, ischemic cardiomyopathy, and other secondary cardiomyopathies.
    Waagstein F
    Heart Vessels Suppl; 1991; 6():18-28. PubMed ID: 1687923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
    Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H; Seiler A; Mahler F
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat.
    Alvarez-Guerra M; Alda O; Garay RP
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic effects of intravenously administered celiprolol in patient with coronary heart disease and depressed left ventricular function].
    Leisch F; Herbinger W
    Arzneimittelforschung; 1987 Apr; 37(4):444-6. PubMed ID: 2886131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.